ARCHIVES

Avastin doubles progression-free survival in metastatic disease.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

New Clinical Trials Monitoring Program To Site Visit PIs Every Three Years

July 30, 1982

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

“Comprehensive” Tag For Centers A Poor Choice, Word-Conscious NCI Staff, Committee Feel

February 22, 1974

NIGMS Forms Bioinformatics, Computational Bio Center.

May 25, 2001

Survivorship Research RFA To Be Reissued; Biomedical Imaging Institute Names 10 to Advisory Council

November 29, 2002

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011